Oscar Health Inc (OSCR) Stock Forecast & Price Target
Oscar Health Inc · NYSE
$31.41+3.08 (+10.85%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Oscar Health Inc, 2 rate it Buy or better, 6 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $19.00 to $35.00, a moderate spread. The average target of $24.67 sits 21% below the current $31.41. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.20 next quarter toward $1.51 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Hold
Strong Buy00%
Buy222%
Hold667%
Sell111%
Strong Sell00%
Based on 9 analysts giving stock ratings to Oscar Health Inc.
As of Jul, 2 of 9 firms rate OSCR a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
OSCR EPS & revenue forecast
EPS · NEXT QUARTER
$-0.20
Range $-0.46 – $0.00 · 10 analysts · -62% YoY
Next period, 10 analysts expect Oscar Health Inc to earn $-0.20 a share (range $-0.46 – $0.00), versus $-0.53 a year earlier. Full-year consensus is $1.10, growing to $1.51 the year after.
REVENUE · NEXT QUARTER
$4.6B
Range $4.3B – $4.8B · 10 analysts · +55% YoY
Revenue is expected to reach $4.6B (range $4.3B – $4.8B), +55.5% year-over-year. Full-year consensus is $18.5B, rising to $19.8B next year.
Top analysts covering Oscar Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OSCR.
#1
Andrew Mok
Barclays
Buy
$35.00+11.4% to target
Coverage
—
+ Follow
#2
MH
Michael Ha
Baird
Hold
$19.00-39.5% to target
Coverage
—
+ Follow
#3
JL
Justin Lake
Wolfe Research
Hold
No targeton OSCR
Coverage
—
+ Follow
#4
AM
Andrew Mok CFA
Barclays
Hold
$21.00-33.2% to target
Coverage
—
+ Follow
#5
JY
Jonathan Yong
UBS
Hold
$20.00-36.3% to target
Coverage
—
+ Follow
OSCR stock forecast FAQ
What is OSCR's average 12-month price target?+
The 3 analysts with a live target average $24.67 for Oscar Health Inc over the next 12 months, ranging from a $35.00 high to a $19.00 low.
Is OSCR stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 9 analyst ratings, 2 are Buy or Strong Buy, 6 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for OSCR?+
The Street-high target is $35.00 (Barclays), and the Street-low is $19.00 (Baird). The average of all 3 active targets is $24.67.
How many Wall Street analysts cover OSCR?+
9 analysts have an active rating on Oscar Health Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering OSCR?+
Among analysts who currently cover OSCR, Andrew Mok of Barclays has the strongest overall Quantellect track record. Their current call is Buy with a $35.00 target.
What is Oscar Health Inc's projected EPS for next quarter?+
The consensus estimate is $-0.20 per share (range $-0.46 – $0.00) across 10 analysts. Full-year EPS is projected at $1.10, rising to $1.51 the following year.
How much revenue is Oscar Health Inc expected to report next quarter?+
Consensus revenue is $4.6B (range $4.3B – $4.8B). Full-year revenue is projected at $18.5B, growing to $19.8B next year.
Have analysts been upgrading or downgrading OSCR lately?+
As of Jul, 2 of 9 firms rate OSCR a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OSCR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
